Breathing Device Therapy Before and After Hip Fracture Surgery
Tests a breathing device, PEP therapy, to prevent pneumonia in adults with hip fracture.
Plain-language title generated from the registry record
Registry title: Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Key facts
- Where
- Copenhagen and Herlev, DenmarkSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a hip fracture who can understand the study and give consent. It tests chest breathing therapy (PEP) before and after surgery to prevent pneumonia.
- Age
- 18 years and older
- Sex
- Men and women can both join.
- Disease stage
- Hip fracture, at any age within the adult range.
Main reasons for not taking part
- Cognitive impairment
- Cannot understand the study and give informed consent
- Pneumonia when admitted to hospital
- Delirium when admitted to hospital
- Pneumothorax (air outside the lung)
Read by machine on 12 November 2026.
Where in Denmark
- Bispebjerg-Frederiksberg HospitalCopenhagen, DenmarkContact: Ditte Stensgaard AndreasenTaking people
- Herlev & Gentofte HospitalHerlev, DenmarkContact: Camilla PaaskeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital Bispebjerg and Frederiksberg
- Trial code
- NCT07189260
- Record updated
- 23 September 2025
- Original description
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.Read full original descriptionShow less
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia in Patients Undergoing Hip Fracture Surgery
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.
* Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture? * Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia.
Participants will:
* Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment * Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.
Inclusion: Hip fracture regardless of age; Cognitively well-functioning; Able to understand the study and give informed consent; Able to speak and understand Danish; Resident of Region Hovedstaden or Region Sjælland.
Exclusion: Pneumothorax; For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually; Cognitively impaired; Unable to understand the study and give informed consent; Pneumonia upon admission; Delirium upon admission.